Cited 0 time in
Genomic Approach to the Assessment of Adverse Effects of Particulate Matters on Skin Cancer and Other Disorders and Underlying Molecular Mechanisms
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kee, Nam Gook | - |
| dc.contributor.author | Kim, Hyun Soo | - |
| dc.contributor.author | Choi, Hyunjung | - |
| dc.contributor.author | Kim, Hyoung-June | - |
| dc.contributor.author | Seo, Young Rok | - |
| dc.date.accessioned | 2023-04-27T15:41:06Z | - |
| dc.date.available | 2023-04-27T15:41:06Z | - |
| dc.date.issued | 2021-09-30 | - |
| dc.identifier.issn | 2288-3649 | - |
| dc.identifier.issn | 2288-3657 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/4418 | - |
| dc.description.abstract | Air pollutants are in the spotlight because the human body can easily be exposed to them. Among air pollutants, the particulate matter (PM) represents one of the most serious toxicants that can enter the human body through various exposure routes. PMs have various adverse effects and classified as severe carcinogen by International Agency for Research on Cancer. Their physical and chemical characteristics are distinguished by their size. In this review, we summarized the published information on the physicochemical characteristics and adverse effects of PMs on the skin, including carcinogenicity. Through comparisons of biological networks constructed from relationships discussed in the previous scientific publications, we show it is possible to predict skin cancers and other disorders from particle-size-specific signaling alterations of PM-responsive genes. Our review not only helps to grasp the biological association between ambient PMs and skin diseases including cancer, but also provides new approaches to interpret chemical-gene-disease associations regarding the adverse effects of these heterogeneous particles. | - |
| dc.format.extent | 9 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | KOREAN SOC CANCER PREVENTION | - |
| dc.title | Genomic Approach to the Assessment of Adverse Effects of Particulate Matters on Skin Cancer and Other Disorders and Underlying Molecular Mechanisms | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.15430/JCP.2021.26.3.153 | - |
| dc.identifier.wosid | 000709702800001 | - |
| dc.identifier.bibliographicCitation | JOURNAL OF CANCER PREVENTION, v.26, no.3, pp 153 - 161 | - |
| dc.citation.title | JOURNAL OF CANCER PREVENTION | - |
| dc.citation.volume | 26 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 153 | - |
| dc.citation.endPage | 161 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART002763781 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | esci | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | LUNG EPITHELIAL-CELLS | - |
| dc.subject.keywordPlus | AIR-POLLUTION | - |
| dc.subject.keywordPlus | HUMAN HEALTH | - |
| dc.subject.keywordPlus | ALLERGIC SENSITIZATION | - |
| dc.subject.keywordPlus | PM2.5 | - |
| dc.subject.keywordPlus | PARTICLES | - |
| dc.subject.keywordPlus | ULTRAFINE | - |
| dc.subject.keywordPlus | FINE | - |
| dc.subject.keywordPlus | KERATINOCYTES | - |
| dc.subject.keywordPlus | EXPRESSION | - |
| dc.subject.keywordAuthor | Air pollutants | - |
| dc.subject.keywordAuthor | Particulate matter | - |
| dc.subject.keywordAuthor | Skin diseases | - |
| dc.subject.keywordAuthor | Carcinogens | - |
| dc.subject.keywordAuthor | Toxicogenetics | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
